The tissue-based genomic profiling market is projected to grow from USD 1.4 billion in 2025 to USD 2.5 billion by 2035, at a CAGR of 6.3%. Tumor Tissue And Liquid DNA Profiling will dominate with a 47.6% market share, while personalized medicine will lead the application segment with a 53.2% share.